Interesting; thanks, trding, my guess was way off...
If GvHD trial is not a cost issue, then I am wondering why no patient hasn't been enrolled yet, since the protocol seems to be fine.
And the same goes for TNBC. Why aren't more clinical sites open?
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-